An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate

Summary

The purpose of this study is to determine the pharmacokinetic and safety profiles of omacetaxine and its metabolites in patients with relapsed and/or refractory hematologic malignancies or advanced solid tumors following subcutaneous (sc) administration.

Timeline

Start

2013-07

Primary completion

2014-12

Completion

2015-01

Drugs

Indications